Printer Friendly

COMPANY INFORMATION
GeneNews Limited Building 2, 2 East Beaver Creek Rd Richmond Hill, ON L4B 2N3 Tel: (905) 739-2030 Toll-free: (866) 375-0442 Fax: (905) 739-2031 Contact Name Casey Gurfinkel Industry Pharmaceuticals		Key Executives Heiner Dreismann, interim CEO Sonny Young, v-p, fin. Develops and commercializes blood-based molecular diagnostic tests for cancer, central nervous system disorders, psychiatric disorders, cardiovascular disease and arthritis.
FP ADVISOR COVERAGE GeneNews Limited • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/GEN $0.27 $0.85 $0.13 n.a. n.a. n.a. 1.16 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 14,112 n.a. $-0.14 Sept. 30/09 96.3% -26.96% -23.17% $16,929
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 1,422 2,168 3,283 Net income (13,172) (9,634) (8,936) Total assets 7,288 18,848 24,700 $ $ $ Earnings per share* (0.24) (0.17) (0.18) % % % Return on equity (166.93) (52.86) (60.25)   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 945 1,089 Net income (7,804) (13,572) $ $ Earnings per share (0.14) (0.25)

COMPANY NEWS

Results for 'GeneNews Limited' from past 30 days: No hits. (Links are to articles.)